Neuropathological alterations in Alzheimer disease

Cited by (1,028)

Items 601–700 of 1,028

1. Supplementation with γ-glutamylcysteine (γ-GC) lessens oxidative stress, brain inflammation and amyloid pathology and improves spatial memory in a murine model of AD
   Liu, Yue, Chen, Zheng, Li, Ben, Yao, Hua, Zarka, Martin, Welch, Jeffrey, Sachdev, Perminder, Bridge, Wallace, Braidy, Nady · 2021 · Neurochemistry International
2. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease
   Juan José Ramos‐Rodríguez, Margarita Jiménez-Palomares, Maria Isabel Murillo-Carretero, Carmen Infante‐Garcia, Esther Berrocoso, Fernando Hernandez Pacho, Alfonso Maria Lechuga-Sancho, Irene Cózar‐Castellano, Mónica Garcı́a-Alloza · 2015 · Psychoneuroendocrinology
3. Radiological-Pathological Correlation in Alzheimer’s Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings
   Caroline Dallaire‐Théroux, Brandy L. Callahan, Olivier Potvin, Stéphan Saïkali, Simon Duchesne · 2017 · Journal of Alzheimer s Disease
4. Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use
   Cristina d’Abramo, Luciano D'adamio, Luca Giliberto · 2020 · Journal of Personalized Medicine
5. Comparison of memory, affective behavior, and neuropathology in APPNLGF knock-in mice to 5xFAD and APP/PS1 mice
   Andrea Locci, Hector Orellana, Guadalupe Rodríguez, Meredith Gottliebson, Bryan M. McClarty, Sky Dominguez, Rachel M. Keszycki, Hongxin Dong · 2021 · Behavioural Brain Research
6. Intelligent Sensing Technologies for the Diagnosis, Monitoring and Therapy of Alzheimer’s Disease: A Systematic Review
   Nazia Gillani, Tughrul Arslan · 2021 · Sensors
7. Integrated platform for multiscale molecular imaging and phenotyping of the human brain
   Juhyuk Park, Ji Wang, Webster Guan, Lars Gjesteby, Dylan Pollack, Lee D. Kamentsky, Nicholas B. Evans, Jeff Stirman, Xinyi Gu, Chuanxi Zhao et al. · 2024 · Science
8. Recent advances in biosensors for neurodegenerative disease detection
   Hashwin V. S. Ganesh, Ari M. Chow, Kağan Kerman · 2016 · TrAC Trends in Analytical Chemistry
9. Altered Functional Connectivity of Cognitive-Related Cerebellar Subregions in Alzheimer’s Disease
   Weimin Zheng, Xingyun Liu, Haiqing Song, Kuncheng Li, Zhi­qun Wang · 2017 · Frontiers in Aging Neuroscience
10. Targeting Tau Hyperphosphorylation via Kinase Inhibition: Strategy to Address Alzheimer's Disease
    Ahmad Abu Turab Naqvi, Gulam Mustafa Hasan, Md. Imtaiyaz Hassan · 2020 · Current Topics in Medicinal Chemistry
11. Role of Fluid Biomarkers and PET Imaging in Early Diagnosis and its Clinical Implication in the Management of Alzheimer’s Disease
    Shahul Hameed, Jong‐Ling Fuh, Vorapun Senanarong, Esther Gunaseli M. Ebenezer, Irene Looi, Jacqueline C. Dominguez, Kyung Won Park, Ananda Krishna Karanam, Oliver Simon · 2020 · Journal of Alzheimer s Disease Reports
12. Role of extracellular vesicles in neurodegenerative diseases
    Yun Xiao, Shu-Kun Wang, Yuan Zhang, Abdolmohamad M. Rostami, Anshel Kenkare, Giacomo Casella, Zengqiang Yuan, Xing Li · 2021 · Progress in Neurobiology
13. Central nervous system diseases related to pathological microglial phagocytosis
    Ke Wang, Jiaying Li, Yue Zhang, Yichen Huang, Di Chen, Ziyu Shi, Amanda D. Smith, Wei Li, Yanqin Gao · 2021 · CNS Neuroscience & Therapeutics
14. Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer’s Disease
    Del Amo, Laura, Cano, Amanda, Ettcheto, Miren, Souto, Eliana B., Espina, Marta, Camins, Antoni, García, Maria Luísa, Sánchez-López, Elena · 2021 · Applied Sciences
15. Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease
    Zhuohang Liu, Hang Li, Shuyi Pan · 2021 · Frontiers in Genetics
16. Insulin protects against Aβ-induced spatial memory impairment, hippocampal apoptosis and MAPKs signaling disruption
    Rasoul Ghasemi, Asadollah Zarifkar, Karim Rastegar, Nader Maghsoudi, Maryam Moosavi · 2014 · Neuropharmacology
17. Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine
    Susana Cardoso, Cristina Carvalho, Sónia C. Correia, Raquel Maria Fino Seiça, Paula Isabel Moreira · 2016 · Brain Pathology
18. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale
    Nicolas Ruffini, Susanne Klingenberg, Susann Schweiger, Susanne Gerber · 2020 · Cells
19. Tau imaging in the study of ageing, Alzheimer's disease, and other neurodegenerative conditions
    Victor L. Villemagne, Nobuyuki Okamura · 2015 · Current Opinion in Neurobiology
20. Delivering Crocetin across the Blood-Brain Barrier by Using γ-Cyclodextrin to Treat Alzheimer’s Disease
    Ka Hong Wong, Yuning Xie, Xiao Li Huang, Kazunori Kadota, Xin‐Sheng Yao, Yang Yu, Xiaoyu Chen, Aiping Lü, Zhijun Yang · 2020 · Scientific Reports
21. Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer’s disease and Parkinson’s disease: a large-scale multi-trait association analysis
    Ping Guo, Weiming Gong, Yuanming Li, Lu Liu, Ran Yan, Yanjun Wang, Yanan Zhang, Zhongshang Yuan · 2022 · BMC Medicine
22. Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease: Insights into Pathophysiology and Treatment
    Alkhalifa, Amer E., Alkhalifa, Oula, Durdanovic, Iva, Ibrahim, Dalia R., Maragkou, Sofia · 2025 · Journal of Dementia and Alzheimer's Disease
23. Structure–Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer Disease
    Tetsuro Tago, Shozo Furumoto, Nobuyuki Okamura, Ryuichi Harada, Hajime Adachi, Yoichi Ishikawa, Kazuhiko Yanai, Ren Iwata, Yukitsuka Kudo · 2015 · Journal of Nuclear Medicine
24. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease
    Kenichi Ota, Naoya Oishi, Kengo Ito, Hidenao Fukuyama · 2015 · Journal of Neuroscience Methods
25. Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer’s Disease via Peroxisome Proliferator-Activated Receptor α
    Sujyoti Chandra, Kalipada Pahan · 2019 · Journal of Alzheimer s Disease Reports
26. Inhibition of Aquaporin 4 Decreases Amyloid Aβ40 Drainage Around Cerebral Vessels
    Gabriela Camelia Roşu, Bogdan Cătălin, Tudor Adrian Bălşeanu, Laurenţiu Mogoantă, Claudiu Mărgăritescu, Samir Kumar‐Singh, Daniel Nicolae Pirici · 2020 · Molecular Neurobiology
27. Metabolic Regulation of Glia and Their Neuroinflammatory Role in Alzheimer's Disease
    Preeti Kumari, Anika Sood, Valencia Fernandes · 2021 · Cellular and Molecular Neurobiology
28. Perivascular spaces as a potential biomarker of Alzheimer’s disease
    Miranda Lynch, William Pham, Benjamin Sinclair, Terence John O'Brien, Meng Law, Lucy E. Vivash · 2022 · Frontiers in Neuroscience
29. Digital automation of transdermal drug delivery with high spatiotemporal resolution
    Yihang Wang, Ze-Ka Chen, Brayden Davis, Will Lipman, Sicheng Xing, Lin Zhang, Tian Wang, Priyash Hafiz, Wanrong Xie, Zijie Yan et al. · 2024 · Nature Communications
30. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer’s disease and type 2 diabetes
    Carmen Infante‐Garcia, Juan José Ramos‐Rodríguez, Lucia Galindo-Gonzalez, Mónica Garcı́a-Alloza · 2015 · Psychoneuroendocrinology
31. Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes
    Ana Carolina Buzzo Stefanini, Bianca Rodrigues da Cunha, Tiago Henrique, Eloíza H. Tajara · 2015 · Disease Markers
32. Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?
    Debby Van Dam, Yannick Vermeiren, Alain D. Dekker, Petrus J.W. Naudé, Peter Paul De Deyn · 2016 · Current Alzheimer Research
33. N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
    Oliver Wirths, Susanne Walter, Inga Kraus, Hans‐Wolfgang Klafki, Martina Stazi, Timo Jan Oberstein, Jorge A. Ghiso, Jens Wiltfang, Thomas A. Bayer, Sascha Weggen · 2017 · Alzheimer s Research & Therapy
34. β-Amyloid Induces Pathology-Related Patterns of Tau Hyperphosphorylation at Synaptic Terminals
    Hsin‐Yi Wu, Po-Cheng Kuo, Yi-Ting Wang, Hao-Tai Lin, Allyson D. Roe, Bo Y. Wang, Chia‐Li Han, Bradley T. Hyman, Yu‐Ju Chen, Hwan‐Ching Tai · 2018 · Journal of Neuropathology & Experimental Neurology
35. K284-6111 prevents the amyloid beta-induced neuroinflammation and impairment of recognition memory through inhibition of NF-κB-mediated CHI3L1 expression
    Ji Yeon Choi, In Jun Yeo, Ki Cheon Kim, Won Rack Choi, Jae‐Kyung Jung, Sang‐Bae Han, Jin Tae Hong · 2018 · Journal of Neuroinflammation · Retracted
36. Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease
    Yu Jie Ding, Jiahui Zhao, Xunle Zhang, Shanshan Wang, Kirsten L. Viola, Frances Elaine Chow, Yang Zhang, Carol Frances Lippa, William L. Klein, Yuesong Gong · 2019 · Frontiers in Neurology
37. The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases
    Filippo Baldacci, Sonia Mazzucchi, Alessandra Della Vecchia, Linda Giampietri, Nicola Giannini, Maya Koronyo‐Hamaoui, Roberto Ceravolo, Gabriele Siciliano, Ubaldo Bonuccelli, Fanny M. Elahi et al. · 2020 · Expert Review of Molecular Diagnostics
38. Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer’s Disease
    Cátia S. Janota, Cynthia Ann Lemere, María Alexandra Brito · 2015 · Molecular Neurobiology
39. The two faces of synaptic failure in AppNL-G-F knock-in mice
    Amira Latif‐Hernandez, Victor Sabanov, Tariq Ahmed, Katleen Craessaerts, Takashi Saito, Takaomi C. Saido, Detlef Balschun · 2020 · Alzheimer s Research & Therapy
40. Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1−42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease
    Nazia Siddiqui, Javed Ali, Suhel Parvez, Saima Zameer, Abul Kalam Najmi, Mohd Akhtar · 2021 · Neuropharmacology
41. Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer’s disease alleviates amyloid-related pathologies in mice
    Yangyang Duan, Ye Tao, Zhe Qu, Yuewen Chen, Abigail Miranda, Xiaopu Zhou, Ka-Chun Lok, Yu Chen, Amy K.Y. Fu, Viviana Gradinaru et al. · 2021 · Nature Biomedical Engineering
42. Insulin‐degrading enzyme: an ally against metabolic and neurodegenerative diseases
    Luís Sousa, Mariana Guarda, Maria João Meneses, Maria Paula Macedo, Hugo Vicente Miranda · 2021 · The Journal of Pathology
43. Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer’s Disease
    Morteza Abyadeh, Vivek Gupta, Veer Bala Gupta, Nitin Chitranshi, Yunqi Wu, Ardeshir Amirkhani, Anna Meyfour, Samran Sheriff, Ting Shen, Kunal Dhiman et al. · 2021 · Aging and Disease
44. A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer’s disease
    Haque, Rafi, Watson, Caroline M., Liu, Jiaqi, Carter, E. Kathleen, Duong, Duc M., Lah, James J., Wingo, Aliza P., Roberts, Blaine R., Johnson, Erik C. B., Saykin, Andrew J. et al. · 2023 · Science Translational Medicine
45. Research progress on the role of extracellular vesicles in neurodegenerative diseases
    Zhengzhe Li, Xiaoling Wang, Xiaoxing Wang, Xiaomei Yi, Yin Kwan Wong, Jiyang Wu, Fangfang Xie, Die Hu, Qi Wang, Jigang Wang et al. · 2023 · Translational Neurodegeneration
46. The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges
    Huiting Zheng, Huimin Sun, Qixu Cai, Hwan‐Ching Tai · 2024 · International Journal of Molecular Sciences
47. Alzheimer’s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery
    Yanru Ji, Xiaoling Chen, Zhen Wang, Connor Joseph Meek, Jenna Lillie McLean, Yang Yang, Chongli Yuan, Jean‐Christophe Rochet, Fei Liu, Ranjie Xu · 2025 · Molecular Psychiatry
48. Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?
    Michael Beekes, Achim Thomzig, Walter Schulz‐Schaeffer, Reinhard Burger · 2014 · Acta Neuropathologica
49. Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer’s Disease
    Juan José Ramos‐Rodríguez, Tara L. Spires‐Jones, Amy M. Pooler, Alfonso Maria Lechuga-Sancho, Brian J. Bacskai, Mónica Garcı́a-Alloza · 2016 · Molecular Neurobiology
50. Effect of Metformin on Adult Hippocampal Neurogenesis: Comparison with Donepezil and Links to Cognition
    Sara Atito Ali Ahmed, Zahra Mahmood, Aneela Javed, Shoaib Naiyer Hashmi, Inga Zerr, Saima Zafar, Saadia Zahid · 2017 · Journal of Molecular Neuroscience
51. Flavonoids – Food Sources, Health Benefits, and Mechanisms Involved
    Aleksandra Kozłowska, Dorota Ewa Szostak-Węgierek · 2019 · Reference series in phytochemistry
52. Arsenic Exposure Contributes to the Bioenergetic Damage in an Alzheimer’s Disease Model
    Sandra Aurora Niño, Adriana Morales-Martínez, Érika Chi-Ahumada, Leticia Carrizales, Roberto Salgado‐Delgado, Francisca Pérez‐Severiano, Sofía Y. Díaz-Cintra, María Esther Jiménez-Capdeville, Sergio Zarazúa · 2018 · ACS Chemical Neuroscience
53. Oleanolic Acid Exerts a Neuroprotective Effect Against Microglial Cell Activation by Modulating Cytokine Release and Antioxidant Defense Systems
    José M. Castellano, Silvia Garcia-Rodriguez, Juan M. Espinosa, María C. Millán-Linares, Mirela Rada, Javier S. Perona · 2019 · Biomolecules
54. Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases
    Shehata Anwar, Vincent Pons, Serge Rivest · 2020 · Cells
55. The Neuropathological Diagnosis of Alzheimer’s Disease—The Challenges of Pathological Mimics and Concomitant Pathology
    Andrew King, István Bódi, Claire Troakes · 2020 · Brain Sciences
56. Oxysterols present in Alzheimer's disease brain induce synaptotoxicity by activating astrocytes: A major role for lipocalin-2
    Erica Staurenghi, Valentina Cerrato, Paola Gamba, Gabriella Testa, Serena Giannelli, Valerio Leoni, Claudio Caccia, Annalisa Buffo, Wendy J. Noble, Beatriz Gomez Perez‐Nievas et al. · 2020 · Redox Biology
57. α– Linolenic acid modulates phagocytosis and endosomal pathways of extracellular Tau in microglia
    Smita Eknath Desale, Subashchandrabose Chinnathambi · 2021 · Cell Adhesion & Migration
58. Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer's disease
    Hatice Kurucu, Martí Colom‐Cadena, Caitlin Davies, Lewis Wilkins, Declan King, Jamie L. Rose, Makis Tzioras, Jane Tulloch, Colin Smith, Tara L. Spires‐Jones · 2021 · European Journal of Neurology
59. Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases
    Chiara Giacomelli, Simona Daniele, Claudia Martini · 2017 · Biochemical Pharmacology
60. A Combination of Resveratrol and Curcumin is Effective Against Aluminum Chloride-Induced Neuroinflammation in Rats
    Amira Zaky, Ahmad Raafat Bassiouny, Mahitab Farghaly, Bassma Mohamed Elsabaa · 2017 · Journal of Alzheimer s Disease
61. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition
    Park, Jong-Chan, Han, Sun-Ho, Cho, Hyun Jin, Byun, Min Soo, Yi, Dahyun, Choe, Young Min, Kang, Seokjo, Jung, Eun Sun, Won, Su Jin, Kim, Eun Hye et al. · 2017 · Alzheimer's Research & Therapy
62. Obesity and brain illness: from cognitive and psychological evidences to obesity paradox
    Vincenzo Monda, Marco La Marra, Raffaella Perrella, Giorgio Caviglia, Alessandro Iavarone, Sergio Chieffi, Giovanni Messina, Marco Carotenuto, Marcellino Monda, Antonietta Messina · 2017 · Diabetes Metabolic Syndrome and Obesity
63. Prevention and Treatment of Alzheimer’s Disease: Biological Mechanisms of Exercise
    Hugo McGurran, Jordan M. Glenn, Erica N. Madero, Nicholas T. Bott · 2019 · Journal of Alzheimer s Disease
64. Peripheral Versus Central Nervous System APOE in Alzheimer’s Disease: Interplay across the Blood-Brain Barrier
    Dustin Chernick, Stephanie Ortiz-Valle, Angela Jeong, Wenhui Qu, Ling Li · 2019 · Neuroscience Letters
65. Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer’s Disease—Could BCHE Genotyping Be Helpful in Alzheimer’s Therapy?
    Jacek Jasiecki, Bartosz Wasąg · 2019 · Biomolecules
66. Naringenin Upregulates AMPK-Mediated Autophagy to Rescue Neuronal Cells From β-Amyloid (1–42) Evoked Neurotoxicity
    Aitizaz Ul Ahsan, Vijay Lakshmi Sharma, Abubakar Wani, Mani Chopra · 2020 · Molecular Neurobiology
67. Establishment of a Human iPSC- and Nanofiber-Based Microphysiological Blood–Brain Barrier System
    Qi, Dianjun, Wu, Shaohua, Lin, Haishuang, Kuss, Mitchell A., Lei, Yuguo, Krasnoslobodtsev, Alexey, Ahmed, Shaheen, Zhang, Chi, Kim, Hyung Joon, Jiang, Peng et al. · 2018 · ACS Applied Materials & Interfaces
68. Effects of APOE Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease
    Dai, Jingting, Johnson, Erik C. B., Dammer, Eric B., Duong, Duc M., Gearing, Marla, Lah, James J., Levey, Allan I., Wingo, Thomas S., Seyfried, Nicholas T. · 2018 · Frontiers in Molecular Neuroscience
69. Tauopathy and neurodegeneration: A role for stress
    Jorge A. Sierra-Fonseca, Kristin L. Gosselink · 2018 · Neurobiology of Stress
70. Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease
    Anna Atlante, Giuseppina Amadoro, Antonella Bobba, Valentina Latina · 2020 · Cells
71. Cognitive Dysfunction in Cats: Update on Neuropathological and Behavioural Changes Plus Clinical Management
    Lorena Sordo, Danièlle Audry Gunn-Moore · 2021 · Veterinary Record
72. The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer’s Disease Pathogenesis
    Jacek Jasiecki, Monika Targońska, Bartosz Wasąg · 2021 · International Journal of Molecular Sciences
73. Sex is a defining feature of neuroimaging phenotypes in major brain disorders
    Lauren E. Salminen, M. Tubi, Joanna K. Bright, S. Thomopoulos, Alyssa Wieand, P. Thompson · 2020 · Human Brain Mapping
74. Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis
    Miaomiao Wang, Gan Tang, Congfa Zhou, Hongmin Guo, Zihui Hu, Qixing Hu, Guilin Li · 2023 · Chemico-Biological Interactions
75. Metabolomic epidemiology offers insights into disease aetiology
    Harriett Fuller, Yiwen Zhu, Jayna C. Nicholas, Haley Chatelaine, Emily Drzymalla, Afrand K. Sarvestani, Sachelly Julián‐Serrano, Usman A. Tahir, Nasa Sinnott-Armstrong, Laura M. Raffield et al. · 2023 · Nature Metabolism
76. Protein Prenylation and Synaptic Plasticity: Implications for Alzheimer’s Disease
    David A. Hottman, Ling Li · 2014 · Molecular Neurobiology
77. Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer’s Disease
    Barbara Troesch, Peter Weber, M. Hasan Mohajeri · 2016 · Nutrients
78. Ginsenoside Rg2 protects PC12 cells against β-amyloid25-35-induced apoptosis via the phosphoinositide 3-kinase/Akt pathway
    Jing Cui, Jiao Wang, Meizhu Zheng, Dongxia Gou, Chunming Liu, Yifa Zhou · 2017 · Chemico-Biological Interactions
79. The Role of Dietary Antioxidants in the Pathogenesis of Neurodegenerative Diseases and Their Impact on Cerebral Oxidoreductive Balance
    Anna Winiarska‐Mieczan, Ewa Baranowska‐Wójcik, Małgorzata Kwiecień, EUGENIUSZ RYSZARD GRELA, Dominik Szwajgier, Katarzyna Kwiatkowska, Bożena Kiczorowska · 2020 · Nutrients
80. Pulse-Chase Proteomics of the App Knockin Mouse Models of Alzheimer’s Disease Reveals that Synaptic Dysfunction Originates in Presynaptic Terminals
    Timothy J. Hark, Nalini R. Rao, Charlotte Castillon, Tamara Basta, Samuel N. Smukowski, Huan Bao, Arun Upadhyay, Ewa K. Bomba-Warczak, Toshihiro Nomura, Eileen T O'Toole et al. · 2020 · Cell Systems
81. Dietary Regulation of Gut-Brain Axis in Alzheimer’s Disease: Importance of Microbiota Metabolites
    Frausto, Dulce M., Forsyth, Christopher B., Keshavarzian, Ali, Voigt, Robin M. · 2021 · Frontiers in Neuroscience
82. A Bayesian Model for the Prediction and Early Diagnosis of Alzheimer's Disease
    Athanasios T. Alexiou, Mantzavinos Vasileios, Nigel H. Greig, Mohammad Amjad Kamal · 2017 · Frontiers in Aging Neuroscience
83. The Non-receptor Tyrosine Kinase Pyk2 in Brain Function and Neurological and Psychiatric Diseases
    Benoit de Pins, Tiago Mendes, Albert Giralt, Jean‐Antoine Girault · 2021 · Frontiers in Synaptic Neuroscience
84. The Role of Resveratrol in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review
    Daiene Santos Buglio, Ledyane Taynara Marton, Lucas Fornari Laurindo, Élen Landgraf Guiguer, Adriano Cressoni Araújo, Rogério Leone Buchaim, Ricardo de Álvares Goulart, Cláudio José Rubira, Sandra Maria Barbalho · 2022 · Journal of Medicinal Food
85. A Single Model Deep Learning Approach for Alzheimer’s Disease Diagnosis
    Fan Zhang, Bo Pan, Pengfei Shao, Peng Liu, Shuwei Shen, Peng Yao, Ronald X. Xu · 2022 · Neuroscience
86. Immunotherapies for Alzheimer’s Disease—A Review
    Zachary Valiukas, Ramya Ephraim, Kathy Tangalakis, Majid Davidson, Vasso Apostolopoulos, Jack Feehan · 2022 · Vaccines
87. The unfolded protein response transcription factor XBP1s ameliorates Alzheimer’s disease by improving synaptic function and proteostasis
    Claudia A. Duran-Aniotz, Natalia Poblete, Catalina Rivera-Krstulović, Álvaro O. Ardiles, Mei-Li Díaz-Hung, Giovanni Tamburini, Carleen Mae P. Sabusap, Yannis Gerakis, Felipe Cabral‐Miranda, Javier Diaz et al. · 2023 · Molecular Therapy
88. Mechanisms of action of coffee bioactive compounds – a key to unveil the coffee paradox
    Fernanda de Souza Machado, Manuel A. Coimbra, M. Dolores del Castillo, Filipe Manuel Coreta-Gomes · 2023 · Critical Reviews in Food Science and Nutrition
89. The Role of Mitochondrial Dysfunction in the Progression of Alzheimer’s Disease
    Claus Desler, Meryl S. Lillenes, Tone Tønjum, Lene Juel Rasmussen · 2017 · Current Medicinal Chemistry
90. Biochemical deficits and cognitive decline in brain aging: Intervention by dietary supplements
    Jit Poddar, Munmun Pradhan, Gargi Ganguly, Sasanka Chakrabarti · 2018 · Journal of Chemical Neuroanatomy
91. Prospects for the application of mesenchymal stem cells in Alzheimer's disease treatment
    Forough Chakari-Khiavi, Sanam Dolati, Aref Chakari-Khiavi, Hossein Abbaszadeh, Leili Aghebati Maleki, Tannaz Pourlak, Amir Mehdizadeh, Mehdi Yousefi · 2019 · Life Sciences
92. Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use
    S. Gavrilova, A. Alvarez · 2020 · Medicinal research reviews (Print)
93. In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease
    Terada, Tatsuhiro, Yokokura, Masamichi, Obi, Tomokazu, Bunai, Tomoyasu, Yoshikawa, Etsuji, Ando, Ichiro, Shimada, Hitoshi, Suhara, Tetsuya, Higuchi, Makoto, Ouchi, Yasuomi · 2019 · Journal of Neurology
94. The roles of astrocytic phagocytosis in maintaining homeostasis of brains
    Se Young Lee, Won‐Suk Chung · 2020 · Journal of Pharmacological Sciences
95. GSK-3β as a target for apigenin-induced neuroprotection against Aβ 25–35 in a rat model of Alzheimer's disease
    Moein Sadat Alireza, Farnaz Nikbakht, Hadiseh Hossein Nia, Fereshteh Golab, Yasaman Khadem, Mahmoud Barati, Somayeh Vazifekhah · 2021 · Neuropeptides
96. Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases
    Tingting Han, Yuxiang Xu, Lin Sun, Makoto Hashimoto, Jianshe Wei · 2023 · Neural Regeneration Research
97. Inflammation as common link to progressive neurological diseases
    Dias-Carvalho, Ana, Sá, Susana Isabel, Carvalho, Félix, Fernandes, Eduarda, Costa, Vera Marisa · 2024 · Archives of Toxicology
98. Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
    Ali Azargoonjahromi, Fatemeh Abutalebian · 2024 · Nutrition & Metabolism
99. The Alzheimer’s disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons
    Orthis Saha, Ana Raquel Melo de Farias, Alexandre Pelletier, Dolores Siedlecki‐Wullich, Bruna Soares Landeira, Johanna Gadaut, Arnaud Carrier, Anaïs-Camille Vreulx, Karine Guyot, Yun Shen et al. · 2024 · Molecular Psychiatry
100. Prediabetes-induced vascular alterations exacerbate central pathology in APPswe/PS1dE9 mice
     Juan José Ramos‐Rodríguez, Oscar Ortiz-Barajas, Carlos Gamero-Carrasco, Pablo Romero de la Rosa, Carmen Infante‐Garcia, Nuria Zopeque-Garcia, Alfonso Maria Lechuga-Sancho, Mónica Garcı́a-Alloza · 2014 · Psychoneuroendocrinology